Pneumococcal Infections
📧 Sign up to get email alerts when something new happens for Pneumococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly [Phase 3]
A Phase 3 trial update reports on the safety and immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in healthy children, adul…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Phase 3]
A Phase 3 clinical trial evaluated safety and immunogenicity of a booster dose of pneumococcal conjugate vaccine in preterm born infants; re…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule [Phase 3]
This Phase 3 study evaluated the safety and immunogenicity of a two-dose schedule of the 10-valent pneumococcal conjugate vaccine and posted…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts [NA]
A completed clinical trial evaluating system-level strategies to improve influenza and pneumococcal vaccination rates through patient outrea…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso [Phase 4]
Phase 4 clinical trial update assessing immunogenicity and reactogenicity of PCV13 in infants and children in Burkina Faso; the study has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea
A post-marketing safety surveillance study evaluating the Synflorix pneumococcal vaccine in Korean infants has completed.
-
CLINICAL_TRIALS withdrawal · 2017-01-10Clinical Trial Update: Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults
This clinical trial evaluating antibodies and memory cells after different pneumococcal vaccines in adults with HIV was withdrawn, with no r…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection [Phase 3]
Phase 3 immunogenicity and safety study of Synflorix pneumococcal vaccine in children at increased risk of pneumococcal infection has comple…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Pneumococcal Reference Standard [Phase 1]
Phase 1 trial of a pneumococcal reference standard has completed, according to the sponsor NIAID.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. [Phase 3]
This is a completed Phase 3 safety and immunogenicity study of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 safety and immunogenicity study evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine; the trial s…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. [Phase 3]
This update reports the completion of a Phase 3 trial evaluating immune memory in children after primary vaccination with pneumococcal conju…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study [Phase 3]
A Phase 3 non-inferiority study evaluated lot-to-lot consistency across three lots of GSK's 10-valent pneumococcal conjugate vaccine.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 study assessing immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine, sponsored by SK Chemicals; the trial status…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Influenza Vaccine and Pneumococcal Vaccine [Phase 4]
Phase 4 clinical trial update on an influenza vaccine and a pneumococcal vaccine, with the study status shown as completed.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults [Phase 1]
This is a Phase 1 study of an investigational pneumococcal vaccine tested at three dose levels in healthy adults; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) [Phase 3]
Phase 3 study of the V110 pneumococcal vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children [Phase 3]
A Phase 3 study evaluating the safety and immunogenicity of a newly developed 23-valent pneumococcal polysaccharide vaccine in Chinese adult…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 trial update reports the completed status of a study using MF59-adjuvanted influenza vaccine in combination with the 23-valent pne…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers [Phase 3]
Phase 3 trial (PneuMum) investigating pneumococcal vaccination of Australian Indigenous mothers has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants [Phase 2]
Phase 2 trial assessing immunogenicity and safety of two formulations of GSK Pneumococcal Vaccine in healthy infants; results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults [Phase 1]
Phase I safety study of a Streptococcus pneumoniae whole-cell vaccine with alum adjuvant (SPWCV+Al) in healthy adults; results posted.
-
CLINICAL_TRIALS research · 2014-05-05Clinical Trial Update: Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
A completed clinical trial evaluating indirect effects of a pneumococcal vaccine on nasopharyngeal carriage.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults [Phase 3]
Phase 3 trial update examining serological response to antipneumococcal vaccination and its effect on Streptococcus pneumoniae nasal carriag…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Early Versus Delayed Pneumococcal Vaccination in HIV [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated early versus delayed pneumococcal vaccination in individuals with HIV and has completed.